MNDA
Basic information
Region (hg38): 1:158831351-158849506
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MNDA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 168 | 168 | ||||
missense | 343 | 32 | 375 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 343 | 201 | 0 |
Variants in MNDA
This is a list of pathogenic ClinVar variants found in the MNDA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-158842158-T-C | not specified | Likely benign (Nov 22, 2021) | ||
1-158842159-G-A | not specified | Likely benign (Feb 13, 2022) | ||
1-158842162-T-A | not specified | Uncertain significance (May 12, 2022) | ||
1-158842162-T-C | not specified | Likely benign (Feb 12, 2022) | ||
1-158842162-T-G | not specified | Uncertain significance (Jul 17, 2022) | ||
1-158842165-A-G | not specified | Likely benign (Jun 02, 2022) | ||
1-158842166-T-C | not specified | Uncertain significance (Jul 27, 2023) | ||
1-158842171-G-A | not specified | Likely benign (May 17, 2022) | ||
1-158842175-A-G | not specified | Uncertain significance (Mar 15, 2024) | ||
1-158842177-T-A | not specified | Likely benign (Apr 07, 2022) | ||
1-158842178-C-G | not specified | Likely benign (May 24, 2022) | ||
1-158842181-T-C | not specified | Likely benign (Mar 19, 2022) | ||
1-158842182-T-C | not specified | Uncertain significance (Dec 18, 2022) | ||
1-158842182-T-G | not specified | Uncertain significance (Feb 25, 2024) | ||
1-158842183-G-T | not specified | Uncertain significance (Jul 11, 2022) | ||
1-158842186-G-A | not specified | Likely benign (Dec 05, 2022) | ||
1-158842192-A-G | not specified | Likely benign (Oct 17, 2021) | ||
1-158842192-A-T | not specified | Likely benign (Apr 11, 2024) | ||
1-158842194-T-A | not specified | Uncertain significance (Jan 15, 2022) | ||
1-158842205-G-T | not specified | Uncertain significance (Jan 28, 2024) | ||
1-158842207-T-A | not specified | Uncertain significance (Dec 04, 2023) | ||
1-158842207-T-C | not specified | Likely benign (Jun 01, 2019) | ||
1-158842208-G-A | not specified | Uncertain significance (Sep 30, 2022) | ||
1-158842211-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
1-158842226-A-G | not specified | Uncertain significance (Nov 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MNDA | protein_coding | protein_coding | ENST00000368141 | 6 | 18190 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.09e-17 | 0.000677 | 125668 | 0 | 6 | 125674 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.994 | 248 | 208 | 1.19 | 0.0000102 | 2670 |
Missense in Polyphen | 69 | 50.614 | 1.3633 | 720 | ||
Synonymous | -1.87 | 100 | 78.8 | 1.27 | 0.00000427 | 761 |
Loss of Function | -1.27 | 22 | 16.4 | 1.34 | 8.20e-7 | 226 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000165 | 0.000158 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000570 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000178 | 0.0000176 |
Middle Eastern | 0.0000570 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May act as a transcriptional activator/repressor in the myeloid lineage. Plays a role in the granulocyte/monocyte cell- specific response to interferon. Stimulates the DNA binding of the transcriptional repressor protein YY1.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0979
Intolerance Scores
- loftool
- 0.963
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.3
Haploinsufficiency Scores
- pHI
- 0.0732
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.448
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.234
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- activation of innate immune response;cellular defense response;cellular response to DNA damage stimulus;negative regulation of B cell proliferation;cellular response to interferon-beta;positive regulation of apoptotic process;neutrophil degranulation;B cell receptor signaling pathway
- Cellular component
- extracellular region;nucleoplasm;nucleolus;azurophil granule lumen;extracellular exosome;ficolin-1-rich granule lumen
- Molecular function
- DNA binding;protein binding